| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,474 |
2,070 |
$918.25 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,330 |
1,137 |
$201.13 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,426 |
2,051 |
$85.08 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
366 |
310 |
$60.88 |
| 85610 |
|
199 |
153 |
$0.00 |
| 84460 |
|
289 |
289 |
$0.00 |
| 80061 |
Lipid panel |
3,139 |
3,124 |
$0.00 |
| 84450 |
|
523 |
521 |
$0.00 |
| 99442 |
|
780 |
756 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
120 |
65 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
88 |
88 |
$0.00 |
| 82274 |
|
347 |
347 |
$0.00 |
| 86703 |
|
628 |
625 |
$0.00 |
| 3078F |
|
603 |
567 |
$0.00 |
| 1033F |
|
101 |
98 |
$0.00 |
| 82540 |
|
449 |
448 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
51 |
51 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
196 |
189 |
$0.00 |
| 84439 |
|
13 |
13 |
$0.00 |
| 3077F |
|
138 |
124 |
$0.00 |
| 82565 |
|
54 |
53 |
$0.00 |
| 77062 |
|
24 |
24 |
$0.00 |
| 86480 |
|
13 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
31 |
30 |
$0.00 |
| 3051F |
|
12 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,605 |
1,598 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,753 |
1,661 |
$0.00 |
| 99443 |
|
403 |
392 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
127 |
126 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
7,061 |
6,311 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,715 |
2,536 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,871 |
3,846 |
$0.00 |
| 85027 |
|
681 |
665 |
$0.00 |
| 82043 |
|
449 |
448 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,174 |
2,044 |
$0.00 |
| 3079F |
|
115 |
111 |
$0.00 |
| 99441 |
|
324 |
314 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
714 |
702 |
$0.00 |
| 4450F |
|
12 |
12 |
$0.00 |
| 3075F |
|
141 |
137 |
$0.00 |
| 90686 |
|
169 |
169 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
88 |
88 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
27 |
$0.00 |
| 87088 |
|
25 |
24 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
110 |
110 |
$0.00 |
| 1111F |
|
117 |
112 |
$0.00 |
| 3074F |
|
498 |
480 |
$0.00 |
| 83735 |
|
75 |
65 |
$0.00 |
| 1220F |
|
84 |
83 |
$0.00 |
| 86780 |
|
55 |
55 |
$0.00 |
| 81001 |
|
27 |
27 |
$0.00 |
| 90656 |
|
69 |
69 |
$0.00 |
| 3044F |
|
319 |
317 |
$0.00 |
| 3080F |
|
13 |
12 |
$0.00 |
| 86592 |
|
12 |
12 |
$0.00 |
| 82728 |
|
12 |
12 |
$0.00 |